ABSTRACT
BACKGROUND: Corticosteroids have become the mainstay treatment in severe COVID-19. However, its role is mild disease is controversial due to lack of robust scientific evidence. This systematic review and meta-analysis were conducted to assess effect of steroids in mild COVID-19 patients. METHODS: PubMed, EMBASE, Web of Science and medRxiv were searched from 31 December 2019 to 14 May 2021 for studies that reported effectiveness of steroids in non-oxygen requiring COVID-19 patients in terms of progressing to severe disease, mortality, duration of fever, duration of viral clearance and length of hospital stay (LOHS). Studies on inhalational steroids, case reports and reviews were excluded. Risk of bias (ROB) was assessed by the Cochrane's ROB tool and ROBANS tool. Quantitative data synthesis was done using the generic inverse variance method. RESULTS: A total of 6411 studies were identified, 2990 articles were screened after exclusion. Seven studies which fit the criteria (involving 2214 non-oxygen requiring COVID-19 patients) were included and analysed. Overall odds of progression to severe disease among the non-oxygen requiring COVID-19 patients receiving steroids was 5.97 [95% confidence interval (CI): 1.27-27.99, I2 = 0%] and odds of death (OR: 1.35, 95% CI: 1.01-1.79; I2 = 0%) as compared to the patients not receiving steroids. Mean duration of fever (7.4 days), duration to viral clearance (18.9 days) and LOHS (20.8 days) were significantly higher in the steroid arm, as compared to that in no-steroid arm (6.7, 16.5 and 15.2 days, respectively). CONCLUSION: Steroids in non-oxygen requiring COVID-19 patients can be more detrimental than beneficial. PROTOCOL REGISTRATION: The study was prospectively registered in PROSPERO (CRD 42021254951).
Subject(s)
COVID-19 , Adrenal Cortex Hormones/therapeutic use , Humans , Length of Stay , SARS-CoV-2 , SteroidsABSTRACT
The COVID-19 pandemic has been especially challenging to the academic international medical (AIM) community. The impact on the field of clinical medicine has been the most pronounced, particularly in the way that education is provided and academic medicine is pursued by clinicians. With the goal of providing top quality, highly relevant content for our membership, the American College of Academic International Medicine (ACAIM) teamed up with our sister organizations, the World Academic Congress of Emergency Medicine (WACEM), the Global Research on Acute conditions Team (GREAT, Rome, Italy and Basel, Switzerland), and EMA-INDIA (Indirapuram, India). The goal of this truly global coalition was to jointly host weekly web meetings that focus on topics relevant to participating stakeholder communities, with additional focus on the ongoing COVID-19 pandemic. Summary of these efforts and outcomes is provided in this article. The following core competencies are addressed in this article: Interpersonal and communication skills;Professionalism;Practice-based learning and improvement
ABSTRACT
The COVID-19 pandemic has been especially challenging to the academic international medical (AIM) community. The impact on the field of clinical medicine has been the most pronounced, particularly in the way that education is provided and academic medicine is pursued by clinicians. With the goal of providing top quality, highly relevant content for our membership, the American College of Academic International Medicine (ACAIM) teamed up with our sister organizations, the World Academic Congress of Emergency Medicine (WACEM), the Global Research on Acute conditions Team (GREAT, Rome, Italy and Basel, Switzerland), and EMA-INDIA (Indirapuram, India). The goal of this truly global coalition was to jointly host weekly web meetings that focus on topics relevant to participating stakeholder communities, with additional focus on the ongoing COVID-19 pandemic. Summary of these efforts and outcomes is provided in this article. © 2020 Wolters Kluwer Medknow Publications. All rights reserved.